Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Bast

Showing results (201-210 of 299) with videos related to

Pageof 30
Sort By:
Cancer Research|October 11, 1991
Requirements for the internalization of a murine monoclonal antibody directed against the HER-2/neu gene product c-erbB-2L A Maier, F J Xu, S Hester, et al.
Progress in Clinical and Biological Research|January 1, 1992
Detection of minimal residual breast cancer in bone marrowC S Johnston, E J Shpall, S Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Lysophosphatidic acid induces urokinase secretion by ovarian cancer cellsT B Pustilnik, V Estrella, J R Wiener, et al.
American Journal of Obstetrics and Gynecology|February 11, 1992
Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-betaA Berchuck, G Rodriguez, G Olt, et al.
Cancer Research|February 15, 1995
Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor betaL J Havrilesky, J A Hurteau, R S Whitaker, et al.
Cancer|November 15, 1995
Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markersS J Skates, F J Xu, Y H Yu, et al.
In Vivo (Athens, Greece)|July 1, 1995
Spectral differences between epitopes in the cronomes of salivary CA130 and CA125A Portela, G Cornélissen, F Halberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 1997
The significance of tumor contamination in the bone marrow from high-risk primary breast cancer patients treated with high-dose chemotherapy and hematopoietic supportJ J Vredenburgh, O Silva, G Broadwater, et al.
Obstetrics and Gynecology|November 1, 1984
Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancerJ S Berek, R C Bast, A Lichtenstein, et al.
American Journal of Obstetrics and Gynecology|July 1, 1984
Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigenR C Bast, T L Klug, E Schaetzl, et al.
Pageof 30

Showing results (201-210 of 299) with videos related to

Sort By:
Pageof 30
Cancer Research|October 11, 1991
Requirements for the internalization of a murine monoclonal antibody directed against the HER-2/neu gene product c-erbB-2L A Maier, F J Xu, S Hester, et al.
Progress in Clinical and Biological Research|January 1, 1992
Detection of minimal residual breast cancer in bone marrowC S Johnston, E J Shpall, S Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Lysophosphatidic acid induces urokinase secretion by ovarian cancer cellsT B Pustilnik, V Estrella, J R Wiener, et al.
American Journal of Obstetrics and Gynecology|February 11, 1992
Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-betaA Berchuck, G Rodriguez, G Olt, et al.
Cancer Research|February 15, 1995
Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor betaL J Havrilesky, J A Hurteau, R S Whitaker, et al.
Cancer|November 15, 1995
Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markersS J Skates, F J Xu, Y H Yu, et al.
In Vivo (Athens, Greece)|July 1, 1995
Spectral differences between epitopes in the cronomes of salivary CA130 and CA125A Portela, G Cornélissen, F Halberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 1997
The significance of tumor contamination in the bone marrow from high-risk primary breast cancer patients treated with high-dose chemotherapy and hematopoietic supportJ J Vredenburgh, O Silva, G Broadwater, et al.
Obstetrics and Gynecology|November 1, 1984
Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancerJ S Berek, R C Bast, A Lichtenstein, et al.
American Journal of Obstetrics and Gynecology|July 1, 1984
Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigenR C Bast, T L Klug, E Schaetzl, et al.
Pageof 30